-
Je něco špatně v tomto záznamu ?
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
S. Elitzur, R. Shiloh, JLC. Loeffen, A. Pastorczak, M. Takagi, S. Bomken, A. Baruchel, T. Lehrnbecher, SK. Tasian, O. Abla, N. Arad-Cohen, I. Astigarraga, M. Ben-Harosh, N. Bodmer, T. Brozou, F. Ceppi, L. Chugaeva, L. Dalla Pozza, S. Ducassou, G....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
ROAD: Directory of Open Access Scholarly Resources
PubMed
38917355
DOI
10.1182/blood.2024024283
Knihovny.cz E-zdroje
- MeSH
- ATM protein * genetika MeSH
- dítě MeSH
- dospělí MeSH
- hematologické nádory * genetika mortalita MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- předškolní dítě MeSH
- teleangiektatická ataxie * genetika komplikace mortalita MeSH
- zárodečné mutace * MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
Ataxia-telangiectasia (A-T) is an autosomal-recessive disorder caused by pathogenic variants (PVs) of the ATM gene, predisposing children to hematological malignancies. We investigated their characteristics and outcomes to generate data-based treatment recommendations. In this multinational, observational study we report 202 patients aged ≤25 years with A-T and hematological malignancies from 25 countries. Ninety-one patients (45%) presented with mature B-cell lymphomas, 82 (41%) with acute lymphoblastic leukemia/lymphoma, 21 (10%) with Hodgkin lymphoma and 8 (4%) with other hematological malignancies. Four-year overall survival and event-free survival (EFS) were 50.8% (95% confidence interval [CI], 43.6-59.1) and 47.9% (95% CI 40.8-56.2), respectively. Cure rates have not significantly improved over the last four decades (P = .76). The major cause of treatment failure was treatment-related mortality (TRM) with a four-year cumulative incidence of 25.9% (95% CI, 19.5-32.4). Germ line ATM PVs were categorized as null or hypomorphic and patients with available genetic data (n = 110) were classified as having absent (n = 81) or residual (n = 29) ATM kinase activity. Four-year EFS was 39.4% (95% CI, 29-53.3) vs 78.7% (95% CI, 63.7-97.2), (P < .001), and TRM rates were 37.6% (95% CI, 26.4-48.7) vs 4.0% (95% CI, 0-11.8), (P = .017), for those with absent and residual ATM kinase activity, respectively. Absence of ATM kinase activity was independently associated with decreased EFS (HR = 0.362, 95% CI, 0.16-0.82; P = .009) and increased TRM (hazard ratio [HR] = 14.11, 95% CI, 1.36-146.31; P = .029). Patients with A-T and leukemia/lymphoma may benefit from deescalated therapy for patients with absent ATM kinase activity and near-standard therapy regimens for those with residual kinase activity.
Azienda Policlinico San Marco Center of Pediatric Hematology Oncology Catania Italy
Cancer Centre for Children The Children's Hospital at Westmead Westmead NSW Australia
Cancers and Blood Disorders Program Children's Minnesota Minneapolis MN
Department of Genetics Institut Curie INSERM U830 and Université Paris Cité Paris France
Department of Hemato Oncology Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands
Department of Oncology The Children's Memorial Health Institute Warsaw Poland
Department of Oncology University Children's Hospital Zurich Zurich Switzerland
Department of Pediatric Hemato Immunology Hôpital Robert Debré Paris France
Department of Pediatric Hemato Oncology CHU Bordeaux Bordeaux France
Department of Pediatric Hemato Oncology Rambam Health Care Campus Haifa Israel
Department of Pediatric Hematology Oncology Agia Sofia Children's Hospital Athens Greece
Department of Pediatric Hematology Oncology Soroka Medical Center Beer Sheva Israel
Department of Pediatric Hematology Oncology University Hospital of Heraklion Heraklion Crete Greece
Department of Pediatrics and Adolescent Medicine Aarhus University Hospital Aarhus Denmark
Department of Pediatrics and Developmental Biology Tokyo Medical and Dental University Tokyo Japan
Department of Pediatrics The University of Texas MD Anderson Cancer Center Houston TX
Department of Statistics and Data Science Hebrew University Jerusalem Israel
Division of Hematology Oncology Hospital For Sick Children Toronto ON Canada
Division of Pediatric Hematology Oncology CHU Sainte Justine Montreal QC Canada
Felsenstein Medical Research Center Faculty of Medicine Tel Aviv University Petah Tikva Israel
Institute of Cancer and Genomic Sciences University of Birmingham Birmingham United Kingdom
Pediatric Hematology Oncology and Stem Cell Transplant Center University of Padua Padua Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018928
- 003
- CZ-PrNML
- 005
- 20241024111104.0
- 007
- ta
- 008
- 241015s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1182/blood.2024024283 $2 doi
- 035 __
- $a (PubMed)38917355
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Elitzur, Sarah $u Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel $1 https://orcid.org/0000000234957578
- 245 10
- $a ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies / $c S. Elitzur, R. Shiloh, JLC. Loeffen, A. Pastorczak, M. Takagi, S. Bomken, A. Baruchel, T. Lehrnbecher, SK. Tasian, O. Abla, N. Arad-Cohen, I. Astigarraga, M. Ben-Harosh, N. Bodmer, T. Brozou, F. Ceppi, L. Chugaeva, L. Dalla Pozza, S. Ducassou, G. Escherich, R. Farah, A. Gibson, H. Hasle, J. Hoveyan, E. Jacoby, J. Jazbec, S. Junk, A. Kolenova, J. Lazic, L. Lo Nigro, N. Mahlaoui, L. Miller, V. Papadakis, L. Pecheux, M. Pillon, I. Sarouk, J. Stary, E. Stiakaki, M. Strullu, TH. Tran, M. Ussowicz, J. Verdu-Amoros, A. Wakulinska, J. Zawitkowska, D. Stoppa-Lyonnet, AM. Taylor, Y. Shiloh, S. Izraeli, V. Minard-Colin, K. Schmiegelow, R. Nirel, A. Attarbaschi, A. Borkhardt
- 520 9_
- $a Ataxia-telangiectasia (A-T) is an autosomal-recessive disorder caused by pathogenic variants (PVs) of the ATM gene, predisposing children to hematological malignancies. We investigated their characteristics and outcomes to generate data-based treatment recommendations. In this multinational, observational study we report 202 patients aged ≤25 years with A-T and hematological malignancies from 25 countries. Ninety-one patients (45%) presented with mature B-cell lymphomas, 82 (41%) with acute lymphoblastic leukemia/lymphoma, 21 (10%) with Hodgkin lymphoma and 8 (4%) with other hematological malignancies. Four-year overall survival and event-free survival (EFS) were 50.8% (95% confidence interval [CI], 43.6-59.1) and 47.9% (95% CI 40.8-56.2), respectively. Cure rates have not significantly improved over the last four decades (P = .76). The major cause of treatment failure was treatment-related mortality (TRM) with a four-year cumulative incidence of 25.9% (95% CI, 19.5-32.4). Germ line ATM PVs were categorized as null or hypomorphic and patients with available genetic data (n = 110) were classified as having absent (n = 81) or residual (n = 29) ATM kinase activity. Four-year EFS was 39.4% (95% CI, 29-53.3) vs 78.7% (95% CI, 63.7-97.2), (P < .001), and TRM rates were 37.6% (95% CI, 26.4-48.7) vs 4.0% (95% CI, 0-11.8), (P = .017), for those with absent and residual ATM kinase activity, respectively. Absence of ATM kinase activity was independently associated with decreased EFS (HR = 0.362, 95% CI, 0.16-0.82; P = .009) and increased TRM (hazard ratio [HR] = 14.11, 95% CI, 1.36-146.31; P = .029). Patients with A-T and leukemia/lymphoma may benefit from deescalated therapy for patients with absent ATM kinase activity and near-standard therapy regimens for those with residual kinase activity.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a ATM protein $x genetika $7 D064007
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a teleangiektatická ataxie $x genetika $x komplikace $x mortalita $7 D001260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mladiství $7 D000293
- 650 12
- $a hematologické nádory $x genetika $x mortalita $7 D019337
- 650 _2
- $a předškolní dítě $7 D002675
- 650 12
- $a zárodečné mutace $7 D018095
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a dospělí $7 D000328
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Shiloh, Ruth $u Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel $u Felsenstein Medical Research Center, Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel
- 700 1_
- $a Loeffen, Jan L C $u Department of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- 700 1_
- $a Pastorczak, Agata $u Department of Pediatrics, Oncology and Hematology, and Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland
- 700 1_
- $a Takagi, Masatoshi $u Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan $1 https://orcid.org/0000000275809184
- 700 1_
- $a Bomken, Simon $u Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom $1 https://orcid.org/0000000191635738
- 700 1_
- $a Baruchel, Andre $u Department of Pediatric Hemato-Immunology, Hôpital Robert Debré, Paris, France
- 700 1_
- $a Lehrnbecher, Thomas $u Division of Hematology, Oncology and Hemostaseology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt/Main, Germany
- 700 1_
- $a Tasian, Sarah K $u Division of Oncology and Center for Childhood Cancer Research, Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA $1 https://orcid.org/0000000313271662
- 700 1_
- $a Abla, Oussama $u Division of Hematology/Oncology, Hospital For Sick Children, Toronto, ON, Canada
- 700 1_
- $a Arad-Cohen, Nira $u Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel
- 700 1_
- $a Astigarraga, Itziar $u Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Pediatric Oncology Group, Bizkaia Health Research Institute, Pediatric Department, Universidad del País Vasco UPV/EHU, Barakaldo, Spain
- 700 1_
- $a Ben-Harosh, Miriam $u Department of Pediatric Hematology-Oncology, Soroka Medical Center, Beer Sheva, Israel $1 https://orcid.org/0000000317159950
- 700 1_
- $a Bodmer, Nicole $u Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland
- 700 1_
- $a Brozou, Triantafyllia $u Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Duesseldorf, Duesseldorf, Germany
- 700 1_
- $a Ceppi, Francesco $u Division of Pediatrics, Pediatric Hematology-Oncology Unit, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Chugaeva, Liliia $u Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation $1 https://orcid.org/0000000232478688
- 700 1_
- $a Dalla Pozza, Luciano $u Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, Australia
- 700 1_
- $a Ducassou, Stephane $u Department of Pediatric Hemato-Oncology, CHU Bordeaux, Bordeaux, France
- 700 1_
- $a Escherich, Gabriele $u Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Farah, Roula $u Department of Pediatrics and Pediatric Hematology/Oncology, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon $1 https://orcid.org/0000000263921590
- 700 1_
- $a Gibson, Amber $u Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX $1 https://orcid.org/0000000291464702
- 700 1_
- $a Hasle, Henrik $u Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark $1 https://orcid.org/0000000339769231
- 700 1_
- $a Hoveyan, Julieta $u Pediatric Cancer and Blood Disorders Center of Armenia, Yeolyan Hematology and Oncology Center and Immune Oncology Research Institute, Yerevan, Armenia $1 https://orcid.org/000900038360356X
- 700 1_
- $a Jacoby, Elad $u Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Sheba Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel $1 https://orcid.org/0000000314118942
- 700 1_
- $a Jazbec, Janez $u Department of Pediatric Hematology and Oncology, University Children's Hospital, Faculty of Medicine, University of Ljubljan, Ljubljana, Slovenia
- 700 1_
- $a Junk, Stefanie $u Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Duesseldorf, Duesseldorf, Germany $1 https://orcid.org/0000000182069463
- 700 1_
- $a Kolenova, Alexandra $u Department of Pediatric Hematology and Oncology, National Institute of Children's Diseases, Comenius University Children's Hospital, Bratislava, Slovakia
- 700 1_
- $a Lazic, Jelena $u Department of Hematology and Oncology, University Children's Hospital, School of Medicine University of Belgrade, Belgrade, Serbia $1 https://orcid.org/0000000274952069
- 700 1_
- $a Lo Nigro, Luca $u Azienda Policlinico, San Marco, Center of Pediatric Hematology Oncology, Catania, Italy $1 https://orcid.org/0000000224801799
- 700 1_
- $a Mahlaoui, Nizar $u Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, French National Reference Center for Primary Immune Deficiencies, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
- 700 1_
- $a Miller, Lane $u Cancers and Blood Disorders Program, Children's Minnesota, Minneapolis, MN
- 700 1_
- $a Papadakis, Vassilios $u Department of Pediatric Hematology-Oncology, Agia Sofia Children's Hospital, Athens, Greece $1 https://orcid.org/0000000218217799
- 700 1_
- $a Pecheux, Lucie $u Department of Pediatric Hematology-Oncology, Stollery Children Hospital, University of Alberta, Edmonton, Canada
- 700 1_
- $a Pillon, Marta $u Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua, Padua, Italy
- 700 1_
- $a Sarouk, Ifat $u Pediatric Pulmonology Unit and Ataxia Telangiectasia Center, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel
- 700 1_
- $a Stary, Jan $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000268187743 $7 jn19990009994
- 700 1_
- $a Stiakaki, Eftichia $u Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, Heraklion Crete, Greece $1 https://orcid.org/0000000233435110
- 700 1_
- $a Strullu, Marion $u Department of Pediatric Hemato-Immunology, Hôpital Robert Debré, Paris, France
- 700 1_
- $a Tran, Thai Hoa $u Division of Pediatric Hematology Oncology, CHU Sainte Justine, Montreal, QC, Canada $1 https://orcid.org/0000000287126233
- 700 1_
- $a Ussowicz, Marek $u Clinical Department of Paediatric Bone Marrow Transplantation, Oncology and Haematology, Wroclaw Medical University, Wroclaw, Poland
- 700 1_
- $a Verdu-Amoros, Jaime $u Department of Pediatric Hematology and Oncology, University Hospital Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain
- 700 1_
- $a Wakulinska, Anna $u Department of Oncology, The Children's Memorial Health Institute, Warsaw, Poland
- 700 1_
- $a Zawitkowska, Joanna $u Department of Pediatric Hematology, Oncology and Transplantation, Medical University of Lublin, Lublin, Poland $1 https://orcid.org/000000017207156X
- 700 1_
- $a Stoppa-Lyonnet, Dominique $u Department of Genetics, Institut Curie, INSERM U830, and Université Paris Cité, Paris, France $1 https://orcid.org/0000000254388309
- 700 1_
- $a Taylor, A Malcolm $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom $1 https://orcid.org/0000000278187595
- 700 1_
- $a Shiloh, Yosef $u Department of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel
- 700 1_
- $a Izraeli, Shai $u Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel $1 https://orcid.org/0000000269382540
- 700 1_
- $a Minard-Colin, Veronique $u Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France $1 https://orcid.org/0000000202965207
- 700 1_
- $a Schmiegelow, Kjeld $u Department of Pediatrics and Adolescent Medicine, Rigshospitalet University Hospital, Copenhagen, Denmark
- 700 1_
- $a Nirel, Ronit $u Department of Statistics and Data Science, Hebrew University, Jerusalem, Israel
- 700 1_
- $a Attarbaschi, Andishe $u Department of Pediatric Hematology and Oncology, St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria $u St Anna Children's Cancer Research Institute, Vienna, Austria $1 https://orcid.org/0000000292856898
- 700 1_
- $a Borkhardt, Arndt $u Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Duesseldorf, Duesseldorf, Germany $1 https://orcid.org/0000000261214737
- 773 0_
- $w MED00000807 $t Blood $x 1528-0020 $g Roč. 144, č. 11 (2024), s. 1193-1205
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38917355 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111058 $b ABA008
- 999 __
- $a ok $b bmc $g 2201653 $s 1230901
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 144 $c 11 $d 1193-1205 $e 20240912 $i 1528-0020 $m Blood $n Blood $x MED00000807
- LZP __
- $a Pubmed-20241015
